Home > Press > NanoInk, Inc. Assets To Be Sold
Abstract:
Moglia Advisors announces an extraordinary acquisition opportunity for an acquisition of equipment and intellectual property in the areas of nano scale brand protection, with FDA approval having been obtained as a "CBE 30" for certain pharmaceutical applications, the life sciences and advanced materials production, as well as education, electronics and engineering processes. This is an unprecedented opportunity to acquire the cutting edge proprietary patents, licenses and related hardware and inventory, in various lots or as a whole, of NanoInk, Inc.. Moglia Advisors serves as sales advisors to Bankruptcy Trustee Deborah K. Ebner.
Due to the unique circumstances surrounding the case, it is unlikely that any similar collection of equipment and intellectual property will come to market in the foreseeable future, making this sale truly one of a kind.
Formerly headquartered in the north suburbs of Chicago, NanoInk holds nearly 400 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, the University of Strathclyde, the University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. The company ceased operations in February of 2013 after its funding sources, who had invested over $150 million in the company, decided to pursue other investment opportunities.
The NanoGuardian assets consist of patents, equipment and inventory related to techniques useful for individually encrypting products with nanoscale features to ensure authenticity and origin, particularly applicable in the pharmaceuticals arena.
The Photomask assets consist of patents covering different dip-pen nanolithography regimes useful in the repair of nanoscale defects in photomasks and other semiconductor / IC devices and materials.
The DPN assets consist of patents, licenses, equipment and inventory useful in the direct deposition of compounds at the nanoscale, using scanning probe microscope tips. These have potential application in the fields of fundamental nanolithography, bioarrays and bioapplications, advanced materials and nanoscale instrumentation and fabrication. This group also includes the instruments, curriculum and support materials for the company's NanoProfessor education program.
These asset groups may be acquired individually or as a whole.
Qualified bids must be submitted by noon Central time on June 17, 2013.
Summary information on the assets, the bankruptcy case and the sales process may be obtained at:
www.NanoInkBankruptcy.net.
The official court docket and filings for case #13-14126 may be viewed at the website for the United States Bankruptcy Court for the Northern District of Illinois, Eastern Division at:
www.ilnb.uscourts.gov.
####
For more information, please click here
Contacts:
Moglia Advisors
1325 Remington Road
Contact:
Gary Wencel, Managing Director
Suite H
Office: 847-884-8282
Schaumburg, IL 60173
Copyright © Moglia Advisors
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
New chip ramps up AI computing efficiency August 19th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Printing/Lithography/Inkjet/Inks/Bio-printing/Dyes
Presenting: Ultrasound-based printing of 3D materials—potentially inside the body December 8th, 2023
Simple ballpoint pen can write custom LEDs August 11th, 2023
Disposable electronics on a simple sheet of paper October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||